Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

6.35
Delayed Data
As of Aug 18
 -0.09 / -1.40%
Today’s Change
5.90
Today|||52-Week Range
25.17
-38.23%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close6.44
Today’s open6.37
Day’s range6.25 - 6.47
Volume219,157
Average volume (3 months)766,236
Market cap$186.8M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-108.51%
Earnings growth (this year)+7.26%
Earnings growth (next 5 years)--
Revenue growth (last year)-47.78%
P/E ratioNM
Price/Sales8.33
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...-0.05-0.75%
ZYMEZymeworks Inc+0.47+6.79%
STMLStemline Therapeutic...-0.15-1.99%
ATHXAthersys Inc+0.02+1.21%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$35.8M
Annual profit (last year)-$85.2M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts